These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31255595)

  • 1. Absorption, distribution, metabolism and excretion of the biomaterials used in Nanocarrier drug delivery systems.
    Su C; Liu Y; Li R; Wu W; Fawcett JP; Gu J
    Adv Drug Deliv Rev; 2019 Mar; 143():97-114. PubMed ID: 31255595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences.
    Zhang A; Meng K; Liu Y; Pan Y; Qu W; Chen D; Xie S
    Adv Colloid Interface Sci; 2020 Oct; 284():102261. PubMed ID: 32942181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fate of nanocarriers as nanomedicines in vivo: important considerations and biological barriers to overcome.
    Moros M; Mitchell SG; Grazú V; de la Fuente JM
    Curr Med Chem; 2013; 20(22):2759-78. PubMed ID: 23627938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy.
    Jeong K; Kang CS; Kim Y; Lee YD; Kwon IC; Kim S
    Cancer Lett; 2016 Apr; 374(1):31-43. PubMed ID: 26854717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, pharmacokinetics and disposition properties of solid lipid nanoparticles (SLNs).
    Wang J; Chen J; Ye N; Luo Z; Lai W; Cai X; Lin Y
    Curr Drug Metab; 2012 May; 13(4):447-56. PubMed ID: 22443539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and in vivo fate of drug loaded chitosan nanoparticles.
    Wei X; Zhang Z; Qian Z
    Curr Drug Metab; 2012 May; 13(4):364-71. PubMed ID: 22443533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs.
    Griffin BT; Guo J; Presas E; Donovan MD; Alonso MJ; O'Driscoll CM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):367-380. PubMed ID: 27320644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art.
    Weber S; Zimmer A; Pardeike J
    Eur J Pharm Biopharm; 2014 Jan; 86(1):7-22. PubMed ID: 24007657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of stimuli-responsive nanocarriers for drug and gene delivery.
    Ganta S; Devalapally H; Shahiwala A; Amiji M
    J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanocarriers in cancer clinical practice: a pharmacokinetic issue.
    Giodini L; Re FL; Campagnol D; Marangon E; Posocco B; Dreussi E; Toffoli G
    Nanomedicine; 2017 Feb; 13(2):583-599. PubMed ID: 27520727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
    Cai Z; Wang Y; Zhu LJ; Liu ZQ
    Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
    Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
    Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
    He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
    Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and disposition of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles.
    Song X; Zhao X; Zhou Y; Li S; Ma Q
    Curr Drug Metab; 2010 Dec; 11(10):859-69. PubMed ID: 21208172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of nanoparticle-based delivery system via inner ear administration.
    Chen G; Zhang X; Yang F; Mu L
    Curr Drug Metab; 2010 Dec; 11(10):886-97. PubMed ID: 21208174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine.
    Chen C; You P
    Drug Des Devel Ther; 2017; 11():1941-1949. PubMed ID: 28721013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacokinetic overview of nanotechnology-based drug delivery systems: an ADME-oriented approach.
    Hamidi M; Azadi A; Rafiei P; Ashrafi H
    Crit Rev Ther Drug Carrier Syst; 2013; 30(5):435-67. PubMed ID: 24099328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement.
    Shen J; Sun M; Ping Q; Ying Z; Liu W
    Nanotechnology; 2010 Jan; 21(2):025101. PubMed ID: 19955616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of CNT-based drug delivery systems.
    Ye R; Wang S; Wang J; Luo Z; Peng Q; Cai X; Lin Y
    Curr Drug Metab; 2013 Oct; 14(8):910-20. PubMed ID: 24016105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, disposition and pharmacokinetics of solid lipid nanoparticles.
    Qi J; Lu Y; Wu W
    Curr Drug Metab; 2012 May; 13(4):418-28. PubMed ID: 22443536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.